title: Results of treatment in hepatic allograft rejection depend on the immunohistologic pattern of the portal T lymphocyte infiltrate.
authors.affiliation: Department of Surgery, Mayo Clinic, Rochester, MN 55905.
authors.forename: J D
authors.initials: JD
authors.lastname: Perkins
authors.forename: J
authors.initials: J
authors.lastname: Rakela
authors.forename: S
authors.initials: S
authors.lastname: Sterioff
authors.forename: P M
authors.initials: PM
authors.lastname: Banks
authors.forename: R H
authors.initials: RH
authors.lastname: Wiesner
authors.forename: R A
authors.initials: RA
authors.lastname: Krom
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001706:Biopsy; D006084:Graft Rejection; D006801:Humans; D008107:Liver Diseases / Q000175:diagnosis / Q000276:immunology*; D016031:Liver Transplantation; D008775:Methylprednisolone / Q000627:therapeutic use; D011168:Portal System; D013601:T-Lymphocytes / Q000145:classification / Q000276:immunology*
chemical_list: D000911:Antibodies, Monoclonal; D008775:Methylprednisolone